Aridis Pharmaceuticals Inc

NASDAQ:ARDS  
0.95
-0.02 (-2.06%)
Earnings Announcements

Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results

Published: 11/21/2022 23:39 GMT
Aridis Pharmaceuticals Inc (ARDS) - Aridis Pharmaceuticals Announces Third Quarter 2022 Financial Results and Business Update.
Aridis Pharmaceuticals Inc - Qtrly Loss per Share $0.47.
Revenue is expected to be $0.46 Million
Adjusted EPS is expected to be -$0.38

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be $0.00

More details on our Analysts Page.